HHealth Read More Scientists unveil new obesity drug that reprograms fat and energy useSeptember 18, 2025 Details of a new drug that aims to treat the underlying causes of obesity are being presented at…
HHealth Read More Exercise found to reduce artery hardening after weight loss in adults with obesitySeptember 17, 2025 Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used…
GGenetics Read More Genetic study shows dual GIPR/GLP1R action curbs binge alcohol useSeptember 15, 2025 New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…